MedTrace Logo

The Effect of Artificial Intelligence Chatbot and Expert Education on Breast Cancer Awareness Among Female Municipal Employees

NCT07749677 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-08-06

No results posted yet for this study

Summary

This study compared two educational approaches for increasing breast cancer awareness among female employees of Eskisehir Odunpazari Municipality. Participants were randomly assigned to receive education using artificial intelligence-generated educational material, education using expert-developed educational material, or no educational intervention. Breast cancer awareness was assessed at baseline, immediately after the intervention, and 2 months after the intervention. The study also assessed participants' digital health literacy.

Conditions

  • Breast Cancer Awareness

Interventions

BEHAVIORAL

Artificial Intelligence Chatbot-Generated Educational Material

A structured educational material was generated using an artificial intelligence chatbot and presented through Google Forms in a conversational question-and-answer format. The content was written in plain language appropriate for female municipal employees aged 18 years or older and covered breast cancer risk factors, signs and symptoms, preventive attitudes, barriers to screening, awareness-related health behaviors, breast self-examination, and treatment methods. Participants accessed the predefined material through a link or QR code. No real-time or personalized chatbot interaction occurred. Both the artificial intelligence chatbot-generated educational material and the expert-developed educational material were evaluated by a panel of nine independent experts, comprising four general surgery specialists and five public health specialists.

BEHAVIORAL

Expert-Developed Educational Material

Breast cancer awareness educational material was developed by the researchers. The material covered breast cancer risk factors, signs and symptoms, preventive attitudes, barriers to screening, awareness-related health behaviors, breast self-examination, and treatment methods. It was evaluated by a panel of nine independent experts, comprising four general surgery specialists and five public health specialists.

Sponsors & Collaborators

  • Odunpazari Municipality

    collaborator UNKNOWN

  • Eskisehir Osmangazi University

    lead OTHER

Principal Investigators

  • EZGİ SALIŞ, MD · Eskisehir Osmangazi University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-11
Primary Completion
2026-05-15
Completion
2026-07-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07749677 on ClinicalTrials.gov